INTERNATIONAL PATENT: INTEGRATED DNA TECHNOLOGIES, INC. FILES APPLICATION FOR "ENGINEERING OF CAS9 VARIANTS THAT POSSESS TARGETED NUCLEASE ACTIVITY WHEN PAIRED WITH SHORT SGRNAS"

GENEVA, Oct. 1 -- INTEGRATED DNA TECHNOLOGIES, INC. (1710 Commercial ParkCoralville, Iowa 52241) filed a patent application (PCT/US2025/020638) for "ENGINEERING OF CAS9 VARIANTS THAT POSSESS TARGETED NUCLEASE ACTIVITY WHEN PAIRED WITH SHORT SGRNAS" on Mar 20, 2025. With publication no. WO/2025/199277, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GLENN, Steve Ehren (c/o Integrated DNA Technologies, Inc.1710 Commercial ParkCoralville, Iowa 52241), VAKULSKAS, Christopher Anthony (c/o Integrated DNA Technologies, Inc.1710 ...